2001
Cerebral Mass Due to Neurocutaneous Melanosis: Eight Years Later
Schaffer J, McNiff J, Bolognia J. Cerebral Mass Due to Neurocutaneous Melanosis: Eight Years Later. Pediatric Dermatology 2001, 18: 369-377. PMID: 11737677, DOI: 10.1046/j.1525-1470.2001.01961.x.Peer-Reviewed Case Reports and Technical NotesConceptsCongenital melanocytic neviGiant congenital melanocytic nevusMagnetic resonance imagingNeurocutaneous melanosisCentral nervous system involvementExcellent long-term outcomesMedium-sized congenital melanocytic nevusMultiple satellite neviSymptomatic neurocutaneous melanosisNervous system involvementAbsence of malignancyLong-term outcomesRight temporal lobePotential surgical interventionAge 5 monthsAge 10 monthsT1-weighted imagesPerivascular collectionsSatellite neviAsymptomatic patientsEarly imagingSurgical interventionSurgical specimenSystem involvementHistologic examination
1999
Follow‐up recommendations for patients with American Joint Committee on Cancer Stages I–III malignant melanoma
Poo‐Hwu W, Ariyan S, Lamb L, Papac R, Zelterman D, Hu G, Brown J, Fischer D, Bolognia J, Buzaid A. Follow‐up recommendations for patients with American Joint Committee on Cancer Stages I–III malignant melanoma. Cancer 1999, 86: 2252-2258. PMID: 10590365, DOI: 10.1002/(sici)1097-0142(19991201)86:11<2252::aid-cncr12>3.0.co;2-q.Peer-Reviewed Original ResearchConceptsCancer stage IAmerican Joint CommitteePatient education programStage IYale Melanoma UnitSurveillance scheduleSymptomatic recurrenceMelanoma UnitSurveillance examinationsJoint CommitteeOverall survival rateStage of diseaseDetection of recurrenceAsymptomatic recurrenceAsymptomatic patientsDistant recurrenceLocoregional recurrenceHazard ratioDisease recurrenceInitial visitMore recurrencesMost recurrencesLate recurrenceMelanoma patientsRecurrence group